NCAM1 and COVID-19: Moreover, an increased frequency of activated CD8+ T cells was observed in COVID-19 convalescent patients, both in CD38+ human leukocyte antigen-DR (HLA-DR)+ cells and CD56+ cells (P = 0.036).